{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:48:54Z","timestamp":1775137734301,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00403-018-1834-8","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T06:07:00Z","timestamp":1525759620000},"page":"505-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review"],"prefix":"10.1007","volume":"310","author":[{"given":"Vanessa W.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Stenehjem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron W. C.","family":"Kamauu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeun Mi","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Morlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"DuVall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"1834_CR1","unstructured":"Cornia R, Patterson OV, Ginter T, DuVall SL (2014) Rapid NLP development with Leo. In: Presented at: AMIA 2014 annual symposium, November 15\u201319, 2014, Washington, DC"},{"key":"1834_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bjd.12333","volume":"169","author":"C Danial","year":"2013","unstructured":"Danial C, Lingala B, Balise R, Oro AE, Reddy S, Colevas A, Chang AL (2013) Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. Br J Dermatol 169:673\u2013676","journal-title":"Br J Dermatol"},{"key":"1834_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613\u2013619","journal-title":"J Clin Epidemiol"},{"key":"1834_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S1351324904003523","volume":"10","author":"D Ferrucci","year":"2004","unstructured":"Ferrucci D, Lally A (2004) UIMA: an architectural approach to unstructured information processing in the corporate research environment. Nat Lang Eng 10:327\u2013348","journal-title":"Nat Lang Eng"},{"key":"1834_CR5","unstructured":"Kamauu AWC, Dastrup E, Agbor S, Wilson A, Yim YM, DuVall SL (2013) Utilization of new diagnosis codes for non-melanoma skin cancers in 2 large nationwide EHR databases. In: Presented at: 29th international conference on pharmacoepidemiology & therapeutic risk management, August 25\u201328, 2013, Montreal"},{"key":"1834_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/0190-9622(91)70108-E","volume":"24","author":"JS Lo","year":"1991","unstructured":"Lo JS, Snow SN, Reizner GT, Mohs FE, Larson PO, Hruza GJ (1991) Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 24:715\u2013719","journal-title":"J Am Acad Dermatol"},{"key":"1834_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jamadermatol.2016.3628","volume":"153","author":"SFK Lubeek","year":"2017","unstructured":"Lubeek SFK, van Vugt LJ, Aben KKH, vande Kerkhof PC, Gerritsen MP (2017) The epidemiology and clinicopathological features of basal cell carcinoma in patients 80 years and older: a systematic review. JAMA Dermatol 153:71\u201378","journal-title":"JAMA Dermatol"},{"key":"1834_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ejca.2013.12.013","volume":"50","author":"M McCusker","year":"2014","unstructured":"McCusker M, Basset-Seguin N, Dummer R, Lewis K, Schadendorf D, Sekulic A, Hou J, Wang L, Yue H, Hauschild A (2014) Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer 50:774\u2013783","journal-title":"Eur J Cancer"},{"key":"1834_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s13671-014-0069-y","volume":"3","author":"SV Mohan","year":"2014","unstructured":"Mohan SV, Chang AL (2014) Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep 3:40\u201345","journal-title":"Curr Dermatol Rep"},{"key":"1834_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1684\/ejd.2015.2546","volume":"25","author":"M Nguyen-Nielsen","year":"2015","unstructured":"Nguyen-Nielsen M, Wang L, Pedersen L, Olesen AB, Hou J, Mackey H, McCusker M, Basset-Seguin N, Fryzek J, Vyberg M (2015) The incidence of metastatic basal cell carcinoma (mBCC) in Denmark, 1997\u20132010. Eur J Dermatol 25:463\u2013468","journal-title":"Eur J Dermatol"},{"key":"1834_CR11","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1056\/NEJMra044151","volume":"353","author":"AI Rubin","year":"2005","unstructured":"Rubin AI, Chen EH, Ratner D (2005) Basal-cell carcinoma. N Engl J Med 353:2262\u20132269","journal-title":"N Engl J Med"},{"key":"1834_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CCO.0b013e32835ff438","volume":"25","author":"A Sekulic","year":"2013","unstructured":"Sekulic A, Mangold AR, Northfelt DW, LoRusso PM (2013) Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol 25:218\u2013223","journal-title":"Curr Opin Oncol"},{"key":"1834_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/1097-0142(19940115)73:2<328::AID-CNCR2820730216>3.0.CO;2-U","volume":"73","author":"SN Snow","year":"1994","unstructured":"Snow SN, Sahl W, Lo JS, Mohs FE, Warner T, Dekkinga JA, Feyzi J (1994) Metastatic basal cell carcinoma. Report of five cases. Cancer 73:328\u2013335","journal-title":"Cancer"},{"key":"1834_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","volume":"10","author":"H Domarus von","year":"1984","unstructured":"von Domarus H, Stevens PJ (1984) Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 10:1043\u20131060","journal-title":"J Am Acad Dermatol"},{"key":"1834_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D313V4J8VJ","volume":"12","author":"A Wadhera","year":"2006","unstructured":"Wadhera A, Fazio M, Bricca G, Stanton O (2006) Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data? Dermatol Online J 12:7","journal-title":"Dermatol Online J"},{"key":"1834_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/aje\/kwt073","volume":"178","author":"S Wu","year":"2013","unstructured":"Wu S, Han J, Li WQ, Li T, Qureshi AA (2013) Basal-cell carcinoma incidence and associated risk factors in US women and men. Am J Epidemiol 178:890\u2013897","journal-title":"Am J Epidemiol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1834-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1834-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1834-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:56:26Z","timestamp":1720281386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1834-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1834-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"24 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SLD and OVP have received research funding through the University of Utah or Western Institute for Biomedical Research from the following for-profit organizations: Amgen Inc., AbbVie Inc., Anolinx LLC, AstraZeneca Pharmaceuticals LP, F. Hoffmann-La Roche Ltd, Genentech Inc., Genomic Health, Inc., Gilead Sciences Inc., HITEKS Solutions Inc., LexisNexis Risk Solutions, Merck & Co., Inc., Mylan Specialty LP, Northrop Grumman Information Systems, Novartis International AG, PAREXEL International Corporation, and Shire PLC. YMM and RM are employees of Genentech. VWS has received research funding through the University of Utah from Anolinx LLC, Merck & Co., Inc., and Pfizer Inc. DDS has received research funding through the University of Utah from the following for-profit organizations: Genentech Inc., AstraZeneca Pharmaceuticals LP, Myriad Genetics, Bristol-Myers Squibb, AbbVie Inc., and Novartis International AG. He has served as a paid consultant to the following for-profit organizations: Bristol-Myers Squibb, Myriad Genetics, Salarius Pharmaceuticals, and BetaCat Pharmaceuticals. AK is an owner of Anolinx.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board and Department of Veterans Affairs (VA) study and data access approvals were obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}